Form 4 for MDT Medtronic
Accepted 2021-08-26 00:00:00 ET · period of report 2021-08-25 · accession 0001127602-21-024366 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-26 | 2021-08-25 | MDT | Martha Geoffrey | CEO, Dir | S - Sale+OE | $132.67 | -11.6K | 95.8K | -11% | -$1.54M |
| DM | 2021-08-26 | 2021-08-25 | MDT | Martha Geoffrey | CEO, Dir | M - OptEx | $61.81 | +11.6K | 97.3K | +14% | +$715.8K |
| DM | 2021-08-26 | 2021-08-25 | MDT | Martha Geoffrey | CEO, Dir | M - OptEx | $0.00 | -11.6K | 17.5K | -40% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-08-25 | S | D | 10,100 | $132.67 | 95,836 | D | — | — | |
| 2 | Common | Ordinary Shares | 2021-08-25 | M | A | 10,100 | $62.76 | 105,936 | D | — | — | |
| 3 | Common | Ordinary Shares | 2021-08-25 | M | A | 1,481 | $55.32 | 97,317 | D | — | — | |
| 4 | Common | Ordinary Shares | 2021-08-25 | S | D | 1,481 | $132.67 | 95,836 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2021-08-25 | M | D | 1,481 | $0.00 | 0 | D | $55.32 · — to 2023-07-29 | 1,481 Ordinary Shares | (F2) This option to purchase 1,808 Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Covidien acquisition, represents the conversion of an option to purchase 1,808 Medtronic Inc. common stock shares for $55.32 per share. This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option. (F3) This option to purchase 20,481 Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Covidien acquisition, represents the conversion of an option to purchase 20,481 Medtronic Inc. common stock shares for $55.32 per share. This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option. |
| 6 | Derivative | Stock Option (Right to Buy) | 2021-08-25 | M | D | 10,100 | $0.00 | 17,519 | D | $62.76 · — to 2024-07-28 | 10,100 Ordinary Shares | (F4) This option to purchase 1,594 Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Covidien acquisition, represents the conversion of an option to purchase 1,594 Medtronic Inc. common stock shares for $62.76 per share. This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option. (F5) This option to purchase 27,619 Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Covidien acquisition, represents the conversion of 27,619 Medtronic common stock shares for $62.76 per share. This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option. |